Effects of Combined Concurrent Training with Cricket Peptide Supplementation on Cardiometabolic and Functional Fitness Parameters in Older Adults

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230208010

Enrollment

Registered

2023-02-08

Start date

2021-10-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults aging combined exercise physical fitness protein supplementation quality of life

Interventions

Participants received isocaloric drinks that do not contain cricket peptides.,Participants performed concurrent training and received isocaloric drinks containing no cricket peptides.,Participants rec

Placebo Comparator No treatment,Experimental Other,Experimental Dietary Supplement,Experimental Other

Placebo,Concurrent training,Cricket peptide,Combined concurrent training and cricket peptide

Eligibility

Sex/Gender

All

Age

55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Males and females aged 55 and over 2. Body mass index between 18.5-27.5 kg/m2 3.Systolic blood pressure equal to or greater than 130 mmHg and/or diastolic blood pressure equal to or greater than 85 mmHg 4. Availability to attend the exercise program three times a week

Exclusion criteria

Exclusion criteria: 1. The allergic reaction with crustaceans 2. Current smoking 3. Unstable and/or uncontrolled cardiovascular diseases 4. Musculoskeletal problems to physical exercise 5. Severe visual impairment 6. Kidneys or livers disease

Design outcomes

Primary

Measure	Time frame
Body composition before and after 12 weeks of intervention Dual-energy X-ray,Physical function before and after 12 weeks of intervention Senior fitness test,Muscle strength before and after 12 weeks of intervention 1RM of bench press and leg press,Insulin-like growth factor-1 before and after 12 weeks of intervention IRMA kits ,Fasting blood glucose before and after 12 weeks of intervention automated analyzer ,Plasma insulin concentration before and after 12 weeks of intervention commercial radioimmunoassay kits ,Lipid profiles before and after 12 weeks of intervention automated colorimetric assay ,Serum hs-CRP concentration before and after 12 weeks of intervention high-sensitivity immunoturbidimetric assay ,Blood pressure before and after 12 weeks of intervention automated sphygmomanometer,Arterial stiffness before and after 12 weeks of intervention pulse wave velocity,Heart rate variability before and after 12 weeks of intervention eMotion Faros	—

Measure

Time frame

Body composition before and after 12 weeks of intervention Dual-energy X-ray,Physical function before and after 12 weeks of intervention Senior fitness test,Muscle strength before and after 12 weeks of intervention 1RM of bench press and leg press,Insulin-like growth factor-1 before and after 12 weeks of intervention IRMA kits ,Fasting blood glucose before and after 12 weeks of intervention automated analyzer ,Plasma insulin concentration before and after 12 weeks of intervention commercial radioimmunoassay kits ,Lipid profiles before and after 12 weeks of intervention automated colorimetric assay ,Serum hs-CRP concentration before and after 12 weeks of intervention high-sensitivity immunoturbidimetric assay ,Blood pressure before and after 12 weeks of intervention automated sphygmomanometer,Arterial stiffness before and after 12 weeks of intervention pulse wave velocity,Heart rate variability before and after 12 weeks of intervention eMotion Faros

—

Secondary

Measure	Time frame
Quality of life before and after 12 weeks of intervention World Health Organization Quality of Life Brief Version Thai	—

Countries

Thailand

Contacts

Public ContactAndaman Klomklorm

Faculty of Sports Science, Kasetsart University

andaman.klo@ku.th0800543047

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026